Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
Schizophrenia Bulletin Open|July 29, 2022
The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for PsychosisStefania Tognin, Anja Richter, Matthew J Kempton, et al.
Schizophrenia Bulletin|December 23, 2025
Gray Matter Volume Abnormalities and the Association with the Trajectory of Symptoms and Functioning in Individuals at Clinical High Risk of PsychosisShuqing Si, Cheryl See, Emily P Hedges, et al.
Psychiatry and Clinical Neurosciences|April 18, 2023
Influence of cannabis use on incidence of psychosis in people at clinical high riskLucy A Chester, Lucia R Valmaggia, Matthew J Kempton, et al.
Psychological Medicine|January 5, 2024
The temporal association between social isolation, distress, and psychotic experiences in individuals at clinical high-risk for psychosisZeynep Akcaoglu, Thomas Vaessen, Eva Velthorst, et al.
Psychological Medicine|January 8, 2025
The effects of recent stressful life events on outcomes in individuals at clinical high risk for psychosis: results from the longitudinal EU-GEI high-risk studyCheryl R Z See, Shuqing Si, Emily Hedges, et al.
Schizophrenia Bulletin|July 25, 2024
Do Cognitive Subtypes Exist in People at Clinical High Risk for Psychosis? Results From the EU-GEI StudyGeorge Gifford, Alessia Avila, Matthew J Kempton, et al.
Depression and Anxiety|February 4, 2016
CRITICAL ANALYSIS OF THE CURRENT TREATMENT GUIDELINES FOR COMPLEX PTSD IN ADULTSAd De Jongh, Patricia A Resick, Lori A Zoellner, et al.
Schizophrenia Bulletin|February 17, 2021
Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis: A Network PerspectiveHui Lin Ong, Adela-Maria Isvoranu, Frederike Schirmbeck, et al.
Schizophrenia Bulletin|August 21, 2021
Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for PsychosisFrederike Schirmbeck, Nadine C van der Burg, Matthijs Blankers, et al.
Molecular Psychiatry|October 20, 2020
Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosisThomas A Pollak, Matthew J Kempton, Conrad Iyegbe, et al.
Pageof 18